Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

460.99
Delayed Data
As of May 22
 +10.98 / +2.44%
Today’s Change
325.35
Today|||52-Week Range
464.40
+25.58%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash535.6M648.7M809.1M535.2M
 
 
 
 
 
Short Term Investment Cash305.3M113.1M160.4M-273.9M
 
 
 
 
 
Cash & Short Term Investments694.0M900.5M1.0B1.0B
 
 
 
 
 
 
ReceivablesReceivables891.8M1.0B1.5B1.6B
 
 
 
 
 
 
InventoriesInventories70.4M128.9M238.6M399.4M
 
 
 
 
 
 
Current AssetsOther Current Assets140.8M120.7M163.5M130.5M
 
 
 
 
 
Current Assets1.8B2.2B2.9B3.2B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross748.6M1.2B1.9B2.5B
 
 
 
 
 
Depreciation-221.6M-254.0M-331.1M-425.5M
 
 
 
 
 
Other Assets5.3M3.0M5.8M20.3M
 
 
 
 
 
Total Assets3.0B3.9B5.6B7.0B
 
 
 
 
 
 
LiabilitiesAccounts Payable61.9M99.5M141.0M135.0M
 
 
 
 
 
Short Term Debt939.0K0.000.00127.3M
 
 
 
Accrued Expenses119.5M291.9M369.9M355.3M
 
 
 
 
 
Other Current Liabilities166.5M462.4M537.0M590.4M
 
 
 
 
 
Other Liabilities298.8M654.7M811.2M1.2B
 
 
 
 
 
 
Total LiabilitiesLong Term Debt504.6M457.7M362.9M351.6M
 
 
 
 
 
Deferred Taxes-231.9M-266.9M-461.9M-825.3M
 
 
 
 
 
Other Liabilities11.3M40.9M115.5M100.4M
 
 
 
 
 
Total Liabilities998.9M1.3B2.0B2.5B
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity2.0B2.5B3.7B4.4B
 
 
 
 
 
Total Shareholder Equity2.0B2.5B3.7B4.4B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding99.7M102.4M104.6M106.0M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.